middle.news
Emyria Launches Global Platform to Serve Psychedelic Drug Sponsors
9:48am on Monday 20th of April, 2026 AEST
•
Healthcare
Read Story
Emyria Launches Global Platform to Serve Psychedelic Drug Sponsors
9:48am on Monday 20th of April, 2026 AEST
Key Points
Launch of Empax Global Partnership Program creates dual-revenue model
Platform operational with North American sponsor Psyence Group
Addresses global bottleneck in clinical delivery capacity for psychedelic therapies
Leverages scarce national infrastructure and trained workforce
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Emyria (ASX:EMD)
OPEN ARTICLE